Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
11/17/2022
CDE Solicits Comments on the Technical Guidelines for Clinical Researc...
11/17/2022
Mirati Therapeutics Sues China's InventisBio for CNY 99M in Trade Sec...
11/17/2022
Marinus Pharma and Tenacia Biotech Tie Up for Ganaxolone Development ...
11/17/2022
IPF Presents Big Opportunities and Challenges for China Drugmakers
11/17/2022
Growing Pains: Charting The Rapid Rise Of Chinese IO (In Vivo - Pharma...
11/16/2022
Kinarus Therapeutics Engages Great Health Companion Group to Explore P...
11/16/2022
CDE Solicits Comments on the Technical Guidelines for Clinical Trials ...
11/16/2022
CDE Solicits Comments on the Technical Guidelines for Clinical Trials ...
11/16/2022
NHC Reorganizes Medical Administration Departments to Emphasize Epidem...
11/16/2022
Harbour Biomed Launches Nona Biosciences to Provide "Ideas to IND" Pre...
11/16/2022
CDE Issues the Measures for Suspension and Resumption of Review Timing...
11/15/2022
NMPA Holds Conference on Promotion of Foreign Trade and Investment
11/15/2022
Biotheus and Hansoh Strike Licensing Deal for its EGFR/MET Bispecific ...
11/15/2022
Simcere and Idorsia Enter into a Licensing Agreement for Daridorexant ...
11/15/2022
WuXi Vaccines Buys Harbour BioMed China Facility
11/15/2022
Highlights on the New Drug Recall Regulation of 2022 (Mondaq)
11/14/2022
Fire Sale! China's "Warren Buffett" Races To Sell Assets (Forbes)
11/14/2022
Surging Beigene Catches Case of Forex Flu (The Bamboo Works)
11/14/2022
Fundraising Continued to Drop in October, No Drugmaker Raised More Tha...
11/14/2022
Cyagen, Neurophth Ink $140 Million Deal For AI-Designed AAV Capsids
11/14/2022
CDE Issues the Technical Guidelines for Clinical R&D of Bispecific Ant...
11/14/2022
BioNTech and Fosun Pharma Receive Special Approvals for Omicron-BA.4/B...
11/14/2022
Snapshot of BMI System Financial Performance in 3Qs/2022
11/11/2022
CDE Issues the Work Procedures for Changes During Drug Registration Ap...
11/11/2022
NMPA Announces Package Insert Revision of Phloroglucinol Injection
11/11/2022
AstraZeneca Launches First Alexion Rare Disease Therapy for Patients i...
11/11/2022
NMPA Solicits Comments on the Special Rules for TCM Registration
11/11/2022
Harbour BioMed Enters into a License and Collaboration Agreement with ...
11/11/2022
Drug R&D and Product Registration News Digest November 2022 (2)
11/11/2022
Review of A Share-listed Chinese MedPharm Cos in Q3/2022
Page:
122
/
775
Total number of articles:
23243
:
[First]
[<<]
[120]
[121]
[122]
[123]
[124]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit